phase readout
saveNCT07368270: Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Diffuse Large B Cell Lymphoma
view source ↗
comments(0)
5-min edit window · permanent after that